ConductScience.org, home

Paper17525342

Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.

Kim H and 2 others. Science, 2007. Cited by 467 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Papers, record 17525342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17525342

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.
PubMed
Journal
Science
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
467
iCite
Relative citation ratio, by iCite
7.8
iCite
Revised in PubMed
2022-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim HHongtae
2Chen JJunjie
3Yu XXiaochun

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BRCA1 ProteinMajor topic
Carrier ProteinsMajor topic
DNAMajor topic
DNA DamageMajor topic
DNA RepairMajor topic
Nuclear ProteinsMajor topic
UbiquitinMajor topic
Amino Acid Sequence
Cell Cycle
Cell Line, Tumor
DNA-Binding Proteins
HeLa Cells
Histone Chaperones
Humans
Molecular Sequence Data
Protein Binding
Protein Structure, Tertiary
RNA, Small Interfering
Radiation, Ionizing

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01CA089239NCI NIH HHSUnited StatesR01CA089239PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17525326Cell signaling. A touching response to damage.https://conductscience.org/library/papers/17525326

Source PubMed

Download CSV of comments and corrections

Cited by345

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 467 citations.

PMIDTitleJournalYearIn PapersSource
42760358Mechanisms and disease relevance of DNA break repair pathway choice.Nat Rev Mol Cell Biol2026https://conductscience.org/library/papers/42760358PubMed
42581301Mechanism of K63-linked polyubiquitin recognition and cleavage by the BRCA1-A complex.Nat Commun2026https://conductscience.org/library/papers/42581301PubMed
42581048A ubiquitin chain-feeding mechanism for BRCA1-A.Nat Commun2026https://conductscience.org/library/papers/42581048PubMed
42511095Whole-Genome Resequencing-Based Selection-Signal and Association Analyses Prioritize Candidate Genes and Haplotypes for PRRS Resistance-Related Traits in Pigs.Animals (Basel)2026https://conductscience.org/library/papers/42511095PubMed
42406631CDW19S coordinates phasic end processing via distinct enzymatic activities.Nucleic Acids Res2026https://conductscience.org/library/papers/42406631PubMed
42401588The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.Nat Commun2026https://conductscience.org/library/papers/42401588PubMed
41889868The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.bioRxiv2026https://conductscience.org/library/papers/41889868PubMed
41555391The mutual regulation of SOX12 and RNF168 modulates cisplatin resistance in esophageal squamous cell carcinoma cells by regulating DNA damage repair.Cell Biosci2026https://conductscience.org/library/papers/41555391PubMed
41359628The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.PLoS Biol2025https://conductscience.org/library/papers/41359628PubMed
41071892Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer.Sci Adv2025https://conductscience.org/library/papers/41071892PubMed
41006228EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers.Nat Commun2025https://conductscience.org/library/papers/41006228PubMed
40523654Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview.Obes Rev2025https://conductscience.org/library/papers/40523654PubMed
40496644Rare SNP in the HELB gene interferes with RPA interaction and cellular function of HELB.NAR Mol Med2025https://conductscience.org/library/papers/40496644PubMed
40419791Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma.Oncogene2025https://conductscience.org/library/papers/40419791PubMed
40240356USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer.Cell Death Dis2025https://conductscience.org/library/papers/40240356PubMed
40097626Molecular glues that inhibit deubiquitylase activity and inflammatory signaling.Nat Struct Mol Biol2025https://conductscience.org/library/papers/40097626PubMed
39588777STK39-mediated amplification of γ-H2A.X promotes homologous recombination and contributes to PARP inhibitor resistance.Nucleic Acids Res2024https://conductscience.org/library/papers/39588777PubMed
39510841BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.Genes Dev2025https://conductscience.org/library/papers/39510841PubMed
39389815DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1.Trends Pharmacol Sci2024https://conductscience.org/library/papers/39389815PubMed
39315145Identification of ubiquitin markers for survival and prognosis of ovarian cancer.Heliyon2024https://conductscience.org/library/papers/39315145PubMed

See all 345 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
UIMC151720Swiss-Prot's referenceshttps://conductscience.org/library/genes/51720NCBI Gene
BARD1580PubTator's text mininghttps://conductscience.org/library/genes/580NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRIP183990PubTator's text mininghttps://conductscience.org/library/genes/83990NCBI Gene
RBBP85932PubTator's text mininghttps://conductscience.org/library/genes/5932NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17525342

GET https://conductscience.org/api/papers/v1/17525342/cited_by?page=2